NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
1.080
-0.030 (-2.70%)
Oct 8, 2026, 1:59 PM EDT - Market open
NMTC Revenue
NeuroOne Medical Technologies had revenue of $1.97M in the quarter ending June 30, 2026, with 16.34% growth. This brings the company's revenue in the last twelve months to $9.47M, up 42.84% year-over-year. In the fiscal year ending September 30, 2025, NeuroOne Medical Technologies had annual revenue of $12.10M with 250.35% growth. That makes NeuroOne Medical Technologies the 36,283rd largest company in the world by revenue and 4,784th in the United States.
Revenue (ttm)
$9.47M
Revenue Growth
+42.84%
P/S Ratio
0.80
Revenue / Employee
$692,706
Employees
18
Market Cap
9.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 12.10M | 8.64M | 250.35% |
| Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
| Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
| Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
| Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
| Sep 30, 2020 | 1.93M | - | - |
| Sep 30, 2019 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | 773.00 | -476.00 | -38.11% |
| Dec 31, 2013 | 1.25K | 328.00 | 35.61% |
| Dec 31, 2012 | 921.00 | -4.48K | -82.94% |
| Dec 31, 2011 | 5.40K | 4.23K | 362.55% |
| Dec 31, 2010 | 1.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IRIDEX | 51.57M |
| Cytosorbents | 37.22M |
| Lifeward | 21.82M |
| Pulsenmore | 14.13M |
| Picard Medical | 6.30M |
| Biomerica | 4.45M |
| IceCure Medical | 3.95M |
| Sintx Technologies | 1.33M |
NMTC News
- 3 days ago - NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order - GlobeNewsWire
- 21 days ago - NeuroOne Medical enters OneRF Trigeminal Nerve Ablation System distribution pact - TheFly
- 21 days ago - NeuroOne Medical enters OneRF Trigeminal Nerve Ablation System distribution pact - TheFly
- 21 days ago - NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement - GlobeNewsWire
- 4 weeks ago - NeuroOne Medical Technologies Transcript: Moody Capital Disruptive Growth & Life Science Conference - Transcripts
- 4 weeks ago - NeuroOne Medical Technologies Slides: Corporate presentation - Filings
- 7 weeks ago - NeuroOne Medical price target lowered to $5 from $13 at Maxim - TheFly
- 1 month ago - NeuroOne Medical Technologies Earnings Call Transcript: Q3 2026 - Transcripts